Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Investigating Characteristics of Quality Peer Mentors with Spinal Cord Injury.

Gainforth H, Giroux E, Shaw R, Casemore S, Clarke T, McBride C, Garnett C, Sweet S.

Arch Phys Med Rehabil. 2019 May 30. pii: S0003-9993(19)30386-7. doi: 10.1016/j.apmr.2019.04.019. [Epub ahead of print]

PMID:
31153855
2.

Trends in and correlates of use of roll-your-own cigarettes: a population study in England 2008-2017.

Jackson SE, Shahab L, Garnett C, Brown J.

Nicotine Tob Res. 2019 May 16. pii: ntz082. doi: 10.1093/ntr/ntz082. [Epub ahead of print]

PMID:
31095329
3.

New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017.

Ollivier C, Sun H, Amchin W, Beghetti M, Berger RMF, Breitenstein S, Garnett C, Gullberg N, Hassel P, Ivy D, Kawut SM, Klein A, Lesage C, Migdal M, Nije B, Odermarsky M, Strait J, de Graeff PA, Stockbridge N.

J Am Heart Assoc. 2019 May 21;8(10):e011306. doi: 10.1161/JAHA.118.011306. No abstract available.

4.

Quantitative Systems Pharmacology Models for a New International Cardiac Safety Regulatory Paradigm: An Overview of the Comprehensive In Vitro Proarrhythmia Assay In Silico Modeling Approach.

Li Z, Garnett C, Strauss DG.

CPT Pharmacometrics Syst Pharmacol. 2019 May 1. doi: 10.1002/psp4.12423. [Epub ahead of print] Review.

5.

A self-report measure of engagement with digital behavior change interventions (DBCIs): development and psychometric evaluation of the "DBCI Engagement Scale".

Perski O, Blandford A, Garnett C, Crane D, West R, Michie S.

Transl Behav Med. 2019 Mar 30. pii: ibz039. doi: 10.1093/tbm/ibz039. [Epub ahead of print]

PMID:
30927357
6.

Correction to: Implications of Individual QT/RR Profiles-Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections.

Malik M, Garnett C, Hnatkova K, Vicente J, Johannesen L, Stockbridge N.

Drug Saf. 2019 Mar;42(3):473. doi: 10.1007/s40264-019-00801-w.

7.

Correction to: Implications of Individual QT/RR Profiles-Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes.

Malik M, Garnett C, Hnatkova K, Vicente J, Johannesen L, Stockbridge N.

Drug Saf. 2019 Mar;42(3):475. doi: 10.1007/s40264-019-00802-9.

8.

How do artistic creative activities regulate our emotions? Validation of the Emotion Regulation Strategies for Artistic Creative Activities Scale (ERS-ACA).

Fancourt D, Garnett C, Spiro N, West R, Müllensiefen D.

PLoS One. 2019 Feb 5;14(2):e0211362. doi: 10.1371/journal.pone.0211362. eCollection 2019.

9.
10.

Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study.

Vicente J, Zusterzeel R, Johannesen L, Ochoa-Jimenez R, Mason JW, Sanabria C, Kemp S, Sager PT, Patel V, Matta MK, Liu J, Florian J, Garnett C, Stockbridge N, Strauss DG.

Clin Pharmacol Ther. 2019 Apr;105(4):943-953. doi: 10.1002/cpt.1303. Epub 2019 Jan 18.

PMID:
30447156
11.

Implications of Individual QT/RR Profiles-Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections.

Malik M, Garnett C, Hnatkova K, Vicente J, Johannesen L, Stockbridge N.

Drug Saf. 2019 Mar;42(3):401-414. doi: 10.1007/s40264-018-0736-1. Erratum in: Drug Saf. 2019 Mar 9;:.

12.

Implications of Individual QT/RR Profiles-Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes.

Malik M, Garnett C, Hnatkova K, Vicente J, Johannesen L, Stockbridge N.

Drug Saf. 2019 Mar;42(3):415-426. doi: 10.1007/s40264-018-0735-2. Erratum in: Drug Saf. 2019 Feb 6;:.

13.

Addition of Infiltration Between the Popliteal Artery and the Capsule of the Posterior Knee and Adductor Canal Block to Periarticular Injection Enhances Postoperative Pain Control in Total Knee Arthroplasty: A Randomized Controlled Trial.

Kim DH, Beathe JC, Lin Y, YaDeau JT, Maalouf DB, Goytizolo E, Garnett C, Ranawat AS, Su EP, Mayman DJ, Memtsoudis SG.

Anesth Analg. 2018 Sep 12. doi: 10.1213/ANE.0000000000003794. [Epub ahead of print]

PMID:
30234517
14.

Behavior Change Techniques Used in Digital Behavior Change Interventions to Reduce Excessive Alcohol Consumption: A Meta-regression.

Garnett CV, Crane D, Brown J, Kaner EFS, Beyer FR, Muirhead CR, Hickman M, Beard E, Redmore J, de Vocht F, Michie S.

Ann Behav Med. 2018 May 18;52(6):530-543. doi: 10.1093/abm/kax029.

15.

The development of Drink Less: an alcohol reduction smartphone app for excessive drinkers.

Garnett C, Crane D, West R, Brown J, Michie S.

Transl Behav Med. 2019 Mar 1;9(2):296-307. doi: 10.1093/tbm/iby043.

16.
17.

Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes.

Malik M, Garnett C, Hnatkova K, Johannesen L, Vicente J, Stockbridge N.

J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):491-503. doi: 10.1007/s10928-018-9587-8. Epub 2018 Apr 12.

18.
19.

Reported Theory Use by Digital Interventions for Hazardous and Harmful Alcohol Consumption, and Association With Effectiveness: Meta-Regression.

Garnett C, Crane D, Brown J, Kaner E, Beyer F, Muirhead C, Hickman M, Redmore J, de Vocht F, Beard E, Michie S.

J Med Internet Res. 2018 Feb 28;20(2):e69. doi: 10.2196/jmir.8807.

20.

Study Design Parameters Affecting Exposure Response Analysis of QT Data: Results From Simulation Studies.

Ferber G, Sun Y, Darpo B, Garnett C, Liu J.

J Clin Pharmacol. 2018 May;58(5):674-685. doi: 10.1002/jcph.1065. Epub 2018 Feb 8.

PMID:
29420838
21.

Correction to: Scientific white paper on concentration-QTc modeling.

Garnett C, Bonate PL, Dang Q, Ferber G, Huang D, Liu J, Mehrotra D, Riley S, Sager P, Tornoe C, Wang Y.

J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):399. doi: 10.1007/s10928-017-9565-6.

PMID:
29330761
22.

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia.

Quek L, Ferguson P, Metzner M, Ahmed I, Kennedy A, Garnett C, Jeffries S, Walter C, Piechocki K, Timbs A, Danby R, Raghavan M, Peniket A, Griffiths M, Bacon A, Ward J, Wheatley K, Vyas P, Craddock C.

Blood Adv. 2016 Dec 14;1(3):193-204. doi: 10.1182/bloodadvances.2016000760. eCollection 2016 Dec 27.

23.

Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes.

Johannesen L, Garnett C, Luo M, Targum S, Sørensen JS, Mehrotra N.

Clin Pharmacol Ther. 2018 Feb;103(2):304-309. doi: 10.1002/cpt.783. Epub 2017 Dec 8.

PMID:
29219167
24.

Scientific white paper on concentration-QTc modeling.

Garnett C, Bonate PL, Dang Q, Ferber G, Huang D, Liu J, Mehrotra D, Riley S, Sager P, Tornoe C, Wang Y.

J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):383-397. doi: 10.1007/s10928-017-9558-5. Epub 2017 Dec 5. Review. Erratum in: J Pharmacokinet Pharmacodyn. 2018 Jan 12;:.

PMID:
29209907
25.

Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the "CiPA" Initiative and Design of a Prospective Clinical Validation Study.

Vicente J, Zusterzeel R, Johannesen L, Mason J, Sager P, Patel V, Matta MK, Li Z, Liu J, Garnett C, Stockbridge N, Zineh I, Strauss DG.

Clin Pharmacol Ther. 2018 Jan;103(1):54-66. doi: 10.1002/cpt.896. Epub 2017 Nov 16. Review.

26.

Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations.

Kaner EF, Beyer FR, Garnett C, Crane D, Brown J, Muirhead C, Redmore J, O'Donnell A, Newham JJ, de Vocht F, Hickman M, Brown H, Maniatopoulos G, Michie S.

Cochrane Database Syst Rev. 2017 Sep 25;9:CD011479. doi: 10.1002/14651858.CD011479.pub2. Review.

27.

Factors Influencing Usability of a Smartphone App to Reduce Excessive Alcohol Consumption: Think Aloud and Interview Studies.

Crane D, Garnett C, Brown J, West R, Michie S.

Front Public Health. 2017 Apr 3;5:39. doi: 10.3389/fpubh.2017.00039. eCollection 2017.

28.

User characteristics of a smartphone app to reduce alcohol consumption.

Garnett C, Crane D, West R, Michie S, Brown J, Winstock A.

Transl Behav Med. 2017 Dec;7(4):845-853. doi: 10.1007/s13142-017-0477-1.

29.

Social Media Use and its Association with Sexual Risk and Parental Monitoring among a Primarily Hispanic Adolescent Population.

Romo DL, Garnett C, Younger AP, Stockwell MS, Soren K, Catallozzi M, Neu N.

J Pediatr Adolesc Gynecol. 2017 Aug;30(4):466-473. doi: 10.1016/j.jpag.2017.02.004. Epub 2017 Feb 17.

PMID:
28216129
30.

Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response.

Earp JC, Mehrotra N, Peters KE, Fiorentino RP, Griebel D, Lee SC, Mulberg A, Röhss K, Sandström M, Taylor A, Tornøe CW, Wynn EL, Van der Walt JS, Garnett C.

J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):272-277. doi: 10.1097/MPG.0000000000001467.

PMID:
27875488
31.

Fixed-dose-rate administration of gemcitabine in cancer-bearing cats: A pilot study.

Garnett CL, Guerrero TA, Rodriguez CO Jr.

Can Vet J. 2016 Nov;57(11):1149-1155.

32.

Advancing Models and Theories for Digital Behavior Change Interventions.

Hekler EB, Michie S, Pavel M, Rivera DE, Collins LM, Jimison HB, Garnett C, Parral S, Spruijt-Metz D.

Am J Prev Med. 2016 Nov;51(5):825-832. doi: 10.1016/j.amepre.2016.06.013.

33.

Commentary on: "Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration".

Garnett C, Johannesen L.

CPT Pharmacometrics Syst Pharmacol. 2016 Sep;5(9):452-4. doi: 10.1002/psp4.12128. Epub 2016 Sep 20. Review.

34.

Evaluating the effectiveness of a smartphone app to reduce excessive alcohol consumption: protocol for a factorial randomised control trial.

Garnett C, Crane D, Michie S, West R, Brown J.

BMC Public Health. 2016 Jul 8;16:536. doi: 10.1186/s12889-016-3140-8.

35.

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.

Quek L, Otto GW, Garnett C, Lhermitte L, Karamitros D, Stoilova B, Lau IJ, Doondeea J, Usukhbayar B, Kennedy A, Metzner M, Goardon N, Ivey A, Allen C, Gale R, Davies B, Sternberg A, Killick S, Hunter H, Cahalin P, Price A, Carr A, Griffiths M, Virgo P, Mackinnon S, Grimwade D, Freeman S, Russell N, Craddock C, Mead A, Peniket A, Porcher C, Vyas P.

J Exp Med. 2016 Jul 25;213(8):1513-35. doi: 10.1084/jem.20151775. Epub 2016 Jul 4.

36.

Can Bias Evaluation Provide Protection Against False-Negative Results in QT Studies Without a Positive Control Using Exposure-Response Analysis?

Ferber G, Zhou M, Dota C, Garnett C, Keirns J, Malik M, Stockbridge N, Darpo B.

J Clin Pharmacol. 2017 Jan;57(1):85-95. doi: 10.1002/jcph.779. Epub 2016 Jul 7.

PMID:
27271102
37.

Operational Characteristics of Linear Concentration-QT Models for Assessing QTc Interval in the Thorough QT and Phase I Clinical Studies.

Garnett C, Needleman K, Liu J, Brundage R, Wang Y.

Clin Pharmacol Ther. 2016 Aug;100(2):170-8. doi: 10.1002/cpt.361. Epub 2016 May 9.

PMID:
26946218
38.

Topic of Timely Interest-Decision Criteria for Negative QT Assessment Using Exposure Response Analysis of Data From Early-Phase Clinical Studies: Letter to the Editor.

Darpo B, Ferber G, Garnett C, Liu J, Stockbridge N.

Ther Innov Regul Sci. 2015 Sep;49(5):717-719. doi: 10.1177/2168479015596022. No abstract available.

PMID:
30227038
39.

A Quantitative Framework to Evaluate Proarrhythmic Risk in a First-in-Human Study to Support Waiver of a Thorough QT Study.

Nelson CH, Wang L, Fang L, Weng W, Cheng F, Hepner M, Lin J, Garnett C, Ramanathan S.

Clin Pharmacol Ther. 2015 Dec;98(6):630-8. doi: 10.1002/cpt.204. Epub 2015 Sep 29.

PMID:
26259519
40.

Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14.

Darpo B, Garnett C, Keirns J, Stockbridge N.

Drug Saf. 2015 Sep;38(9):773-80. doi: 10.1007/s40264-015-0325-5.

PMID:
26162419
41.

Identification of Behavior Change Techniques and Engagement Strategies to Design a Smartphone App to Reduce Alcohol Consumption Using a Formal Consensus Method.

Garnett C, Crane D, West R, Brown J, Michie S.

JMIR Mhealth Uhealth. 2015 Jun 29;3(2):e73. doi: 10.2196/mhealth.3895.

42.

Behavior change techniques in popular alcohol reduction apps: content analysis.

Crane D, Garnett C, Brown J, West R, Michie S.

J Med Internet Res. 2015 May 14;17(5):e118. doi: 10.2196/jmir.4060.

43.

Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates.

Polak S, Pugsley MK, Stockbridge N, Garnett C, Wiśniowska B.

AAPS J. 2015 Jul;17(4):1025-32. doi: 10.1208/s12248-015-9773-1. Epub 2015 May 5. No abstract available.

44.

Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase.

Darpo B, Benson C, Dota C, Ferber G, Garnett C, Green CL, Jarugula V, Johannesen L, Keirns J, Krudys K, Liu J, Ortemann-Renon C, Riley S, Sarapa N, Smith B, Stoltz RR, Zhou M, Stockbridge N.

Clin Pharmacol Ther. 2015 Apr;97(4):326-35. doi: 10.1002/cpt.60.

PMID:
25670536
45.

Normative misperceptions about alcohol use in the general population of drinkers: a cross-sectional survey.

Garnett C, Crane D, West R, Michie S, Brown J, Winstock A.

Addict Behav. 2015 Mar;42:203-6. doi: 10.1016/j.addbeh.2014.11.010. Epub 2014 Nov 18.

46.

Cardiac Safety Research Consortium: can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward.

Darpo B, Garnett C, Benson CT, Keirns J, Leishman D, Malik M, Mehrotra N, Prasad K, Riley S, Rodriguez I, Sager P, Sarapa N, Wallis R.

Am Heart J. 2014 Sep;168(3):262-72. doi: 10.1016/j.ahj.2014.06.003. Epub 2014 Jun 6.

PMID:
25173536
47.

Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions.

Bernstein MB, Garnett CT, Zhang H, Velcich A, Wattenberg MM, Gameiro SR, Kalnicki S, Hodge JW, Guha C.

Cancer Biother Radiopharm. 2014 May;29(4):153-61. doi: 10.1089/cbr.2013.1578. Epub 2014 Apr 2.

48.

Impact of electrocardiographic data quality on moxifloxacin response in thorough QT/QTc studies.

Johannesen L, Garnett C, Malik M.

Drug Saf. 2014 Mar;37(3):183-9. doi: 10.1007/s40264-014-0142-2.

PMID:
24554350
49.

Electrocardiographic data quality in thorough QT/QTc studies.

Johannesen L, Garnett C, Malik M.

Drug Saf. 2014 Mar;37(3):191-7. doi: 10.1007/s40264-014-0140-4.

PMID:
24554349
50.

The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?".

Darpo B, Sarapa N, Garnett C, Benson C, Dota C, Ferber G, Jarugula V, Johannesen L, Keirns J, Krudys K, Ortemann-Renon C, Riley S, Rogers-Subramaniam D, Stockbridge N.

Ann Noninvasive Electrocardiol. 2014 Jan;19(1):70-81. doi: 10.1111/anec.12128. Epub 2013 Dec 30. Review.

PMID:
24372708

Supplemental Content

Loading ...
Support Center